This inventor holds 1 USPTO granted patent. Top assignees: Amgen Inc., The Rockefeller University. Active years: 1998.
Company Filing History:
1 out of 2,069 
1 out of 751 
Years Active: 1998
Title: Mark Matsuo Wurfe: Innovator in Human Serum Proteins
Introduction
Mark Matsuo Wurfe is a notable inventor based in New York, NY (US). He has made significant contributions to the field of biochemistry, particularly in the study of human serum proteins. His innovative work has led to the development of a unique protein that has potential applications in various medical fields.
Latest Patents
Wurfe holds a patent for a novel human serum protein referred to as Afamin. This invention relates to a human serum albumin-like protein that exhibits one or more activities in common with human serum albumin, human alpha-fetoprotein, or human vitamin D binding protein. The protein has an apparent molecular weight of 87 kd as determined by SDS-PAGE. The patent also covers variants of this protein, as well as related genes, vectors, cells, and methods.
Career Highlights
Throughout his career, Wurfe has worked with prominent organizations such as Amgen Inc. and The Rockefeller University. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Wurfe has had the opportunity to work alongside esteemed colleagues, including Henri Stephen Lichenstein and David Edwin Lyons. These collaborations have further enriched his research and innovation in the realm of human serum proteins.
Conclusion
Mark Matsuo Wurfe's contributions to the field of biochemistry, particularly through his patent on Afamin, highlight his role as an innovator in the study of human serum proteins. His work continues to influence research and development in medical applications.